Compounds > 2,2-bis(4-glycidyloxyphenyl)propane
Page last updated: 2024-10-23

2,2-bis(4-glycidyloxyphenyl)propane and Age-Related Osteoporosis

2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Age-Related Osteoporosis in 2 studies

2,2-bis(4-glycidyloxyphenyl)propane: structure

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Y1
Pan, Z1
Chen, F1
Botolin, S1
McCabe, LR1

Other Studies

2 other studies available for 2,2-bis(4-glycidyloxyphenyl)propane and Age-Related Osteoporosis

ArticleYear
Inhibition of PPARĪ³ by bisphenol A diglycidyl ether ameliorates dexamethasone-induced osteoporosis in a mouse model.
    The Journal of international medical research, 2019, Volume: 47, Issue:12

    Topics: Adipogenesis; Adiposity; Animals; Benzhydryl Compounds; Biomarkers; Bone Marrow; Bone Resorption; Co

2019
Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
    Journal of cellular physiology, 2006, Volume: 209, Issue:3

    Topics: Adipocytes; Animals; Benzhydryl Compounds; Biomarkers; Bone Marrow; Cell Differentiation; Cells, Cul

2006